2010
DOI: 10.1038/nature08792
|View full text |Cite
|
Sign up to set email alerts
|

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

Abstract: Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer degeneration of multiple tissues1–3. Patient-specific induced pluripotent stem (iPS) cells4 represent invaluable in vitro models for human degenerative disorders like DC. A cardinal feature of iPS cells is acquisition of indefinite self-renewal capacity, which is accompanied by induction of telomerase reverse transcriptase (TERT)5–7. We investigated whether defects in telomerase function would limit derivation and maintenance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
221
2
3

Year Published

2011
2011
2014
2014

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 293 publications
(237 citation statements)
references
References 38 publications
11
221
2
3
Order By: Relevance
“…iPS-5 P8-14 with elongated telomeres generated chimeras at rates lower than iPS-6 P36-45, and higher than iPS P8-16. These data show that some iPSC lines undergo telomere lengthening during iPS induction and culture following passaging, consistent with previous reports in humans and mice [21,22]. However, a few iPSCs failed to elongate telomeres, particularly at early passages, despite their expression of Oct4 and Nanog, and the ability to form teratomas.…”
Section: Association Of Telomere Length With Pluripotency Of Ipscssupporting
confidence: 92%
“…iPS-5 P8-14 with elongated telomeres generated chimeras at rates lower than iPS-6 P36-45, and higher than iPS P8-16. These data show that some iPSC lines undergo telomere lengthening during iPS induction and culture following passaging, consistent with previous reports in humans and mice [21,22]. However, a few iPSCs failed to elongate telomeres, particularly at early passages, despite their expression of Oct4 and Nanog, and the ability to form teratomas.…”
Section: Association Of Telomere Length With Pluripotency Of Ipscssupporting
confidence: 92%
“…In the past 12 years, elegant studies have revealed mutations in seven genes as a cause of DC, all of which encode telomerase (DKC1, TERT, TERC, NOP10, NHP2, TCAB1) or telomere structural (TINF2) components. Moreover, mutations in some of these genes have been found in familial degenerative disorders without classical DC, including aplastic anemia, myelodysplastic syndrome, and idiopathic pulmonary fibrosis [5] [6,7]. A comparison of the data in these two reports illustrates the advantages and limitations of the iPS approach for modeling human diseases.…”
mentioning
confidence: 96%
“…During reprogramming, TERT is activated and telomerase activity is reconstituted. 59,60 However, this may not be sufficient to rescue all classes of DC patient cells. For example, iPS cell reprogramming of DC patient cells harboring a mutation in TCAB1, a telomerase-associated protein that facilitates trafficking of telomerase to Cajal bodies, [61][62][63] showed that despite wild-type telomerase activity, the ability of telomerase to elongate telomeres was abrogated, because telomerase was mislocalized.…”
Section: Tin2 Hp1 and Telomere Elongation By Telomerasementioning
confidence: 99%